167 related articles for article (PubMed ID: 24064854)
1. [Molecular biology in childhood acute lymphoblastic leukemia (ALL)].
Manabe A
Rinsho Ketsueki; 2013 Oct; 54(10):1999-2005. PubMed ID: 24064854
[No Abstract] [Full Text] [Related]
2. [Childhood acute lymphoblastic leukemia (ALL)].
Manabe A; Hasegawa D
Rinsho Ketsueki; 2013 Jan; 54(1):100-8. PubMed ID: 23391653
[No Abstract] [Full Text] [Related]
3. [Childhood acute lymphoblastic leukemia; pathophysiology and treatment strategy].
Tsurusawa M
Rinsho Ketsueki; 2013 Nov; 54(11):2038-46. PubMed ID: 24305536
[No Abstract] [Full Text] [Related]
4. [Acute lymphoblastic leukemia (ALL)].
Manabe A
Nihon Rinsho; 2012 Apr; 70 Suppl 2():670-5. PubMed ID: 23134026
[No Abstract] [Full Text] [Related]
5. Inheritance and clinical outcome in childhood acute lymphoblastic leukemia.
Jamroziak K; Robak T
Leuk Res; 2009 Jul; 33(7):889-90. PubMed ID: 19243820
[No Abstract] [Full Text] [Related]
6. Molecular diagnostics in the treatment of childhood acute lymphoblastic leukemia.
Rubnitz JE
J Biol Regul Homeost Agents; 2000; 14(3):182-6. PubMed ID: 11037050
[TBL] [Abstract][Full Text] [Related]
7. Biology of childhood acute lymphoblastic leukemia.
Bhojwani D; Yang JJ; Pui CH
Pediatr Clin North Am; 2015 Feb; 62(1):47-60. PubMed ID: 25435111
[TBL] [Abstract][Full Text] [Related]
8. Looking toward the future: novel strategies based on molecular pathogenesis of acute lymphoblastic leukemia.
Abutalib SA; Wetzler M; Stock W
Hematol Oncol Clin North Am; 2009 Oct; 23(5):1099-119, vii. PubMed ID: 19825455
[TBL] [Abstract][Full Text] [Related]
9. Correspondence re: R. Varon et al., Mutations in the Nijmegen breakage syndrome gene (NBS1) in childhood acute lymphoblastic leukemia. Cancer Res., 61: 3570-3572, 2001.
Taylor GM; O'Brien HP; Greaves MF; Ravetto PF; Eden OB
Cancer Res; 2003 Oct; 63(19):6563-4; author reply 6565. PubMed ID: 14559852
[No Abstract] [Full Text] [Related]
10. Biology and treatment of acute lymphoblastic leukemia.
Pieters R; Carroll WL
Hematol Oncol Clin North Am; 2010 Feb; 24(1):1-18. PubMed ID: 20113893
[TBL] [Abstract][Full Text] [Related]
11. [Analysis of clinical features and prognostic significance of CD20 positive childhood precursor B-lineage acute lymphoblastic leukemia].
Nie SS; Zhao WL; Ji ZH
Zhonghua Xue Ye Xue Za Zhi; 2011 Apr; 32(4):275-7. PubMed ID: 21569715
[No Abstract] [Full Text] [Related]
12. Childhood ALL researchers focus on high-risk patients.
Friedrich MJ
J Natl Cancer Inst; 2009 May; 101(10):702-4. PubMed ID: 19436027
[No Abstract] [Full Text] [Related]
13. hTERT promoter methylation and telomere length in childhood acute lymphoblastic leukemia: associations with immunophenotype and cytogenetic subgroup.
Borssén M; Cullman I; Norén-Nyström U; Sundström C; Porwit A; Forestier E; Roos G
Exp Hematol; 2011 Dec; 39(12):1144-51. PubMed ID: 21914494
[TBL] [Abstract][Full Text] [Related]
14. Biology of acute lymphoblastic leukemia (ALL): clinical and therapeutic relevance.
Graux C
Transfus Apher Sci; 2011 Apr; 44(2):183-9. PubMed ID: 21354375
[TBL] [Abstract][Full Text] [Related]
15. Repeats in the kringle IV encoding domains in the Apo(a) gene and serum lipoprotein(a) level do not contribute to the risk for avascular necrosis of the bone (AVN) in pediatric acute lymphoblastic leukemia.
van Beek RD; Bezemer DD; Meijerink JP; de Muinck Keizer-Schrama SM; Haas OA; Te Winkel L; Pieters R; van den Heuvel-Eibrink M
Leukemia; 2006 May; 20(5):879-80. PubMed ID: 16525499
[No Abstract] [Full Text] [Related]
16. Pediatric acute lymphoblastic leukemia: there is no TEL-ing what wonders lie ahead.
Sandoval C
Leuk Res; 2010 Apr; 34(4):418-9. PubMed ID: 19892401
[No Abstract] [Full Text] [Related]
17. Childhood leukemias.
Pui CH
N Engl J Med; 1995 Jun; 332(24):1618-30. PubMed ID: 7753142
[No Abstract] [Full Text] [Related]
18. Strengths and weaknesses of gene association studies in childhood acute lymphoblastic leukemia.
Semsei AF; Antal P; Szalai C
Leuk Res; 2010 Mar; 34(3):269-71. PubMed ID: 19716175
[No Abstract] [Full Text] [Related]
19. CDKN2 deletions have no prognostic value in childhood precursor-B acute lymphoblastic leukaemia.
van Zutven LJ; van Drunen E; de Bont JM; Wattel MM; Den Boer ML; Pieters R; Hagemeijer A; Slater RM; Beverloo HB
Leukemia; 2005 Jul; 19(7):1281-4. PubMed ID: 15843818
[No Abstract] [Full Text] [Related]
20. Detection of residual disease in childhood acute lymphoblastic leukemia.
Machida U; Kami M; Hirai H
N Engl J Med; 1999 Jan; 340(2):153-4. PubMed ID: 9917221
[No Abstract] [Full Text] [Related]
[Next] [New Search]
